Results of an international randomized clinical trial evaluating the PETRUSHKA tool, a web app for personalizing antidepressant treatment, has been published in JAMA. Judit Simon, Professor of Health Economics at the Medical University of Vienna, is co-investigator of the study, which found that patients who received a personalized antidepressant selected using the PETRUSHKA tool were less likely to discontinue their treatment due to any reason. For further details, see the original publication and a linked Editorial